HealthTree Logo
search more_vert
person Sign In / Create Account

Clinical Expertise

  • Myelofibrosis


My basic science research involves hematopoiesis. We investigate the mechanism of apoptosis in megakaryocytes and platelets. We also assess the molecular mechanism by which thrombopoietin is regulated and interacts with its receptor, c-Mpl. My clinical research is focussed on thrombosis/hemostasis and hematopoietic growth factors. We are studying the use of thrombopoietin in ITP, the use of Novel Erythropoiesis-Stimulating Protein (NESP) in anemic chemotherapy patients and the role of thrombopoietin in preventing chemotherapy-induced thrombocytopenia. We are studying the thrombophilia of malignancy and the role of low-molecular weight heparins in its treatment and in the prevention of catheter-related thrombosis.


Massachusetts General Hospital: 55 Fruit St, Boston, MA 02114, USA

Get the latest thought leadership on Myelofibrosis delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myelofibrosis Newsletter" for Myelofibrosis news, life with Myelofibrosis stories, Myelofibrosis clinical trials, Myelofibrosis 101 articles and events with Myelofibrosis experts.

Thanks to our HealthTree Community for Myelofibrosis Sponsors:

Karyopharm Therapeutics

Follow Us

facebook instagram youtube